Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review

doi:10.3748/wjg.v28.i26.3047

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7363)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

418

WORD

HTML

5082

Figures (1-3)

473

Tables (1-2)

381

Sum=6409

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

299

Download

655

Sum=954

Jul 14, 2022 (publication date) through Aug 31, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 14, 2022; 28(26): 3047-3062
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3047

Full Size Figure Download Figure

Figure 1 Increasing trend of publications on “hepatoprotective and anticancer properties of baicalin” indexed by PubMed.

Citation: Ganguly R, Gupta A, Pandey AK. Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review. World J Gastroenterol 2022; 28(26): 3047-3062
URL: https://www.wjgnet.com/1007-9327/full/v28/i26/3047.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i26.3047